Research background · Updated November 1, 2026
Liraglutide Research: Publications, Study Types and Background
Short answer
Liraglutide. As of November 1, 2026, PubMed indexes 5,716 records matching Liraglutide, the earliest from 2003; 2,314 were published in 2021–2025 and 1,655 are reviews. ClinicalTrials.gov lists 551 registered studies matching the compound.
- PubMed records
- 5,716
- Earliest record
- 2003
- Published 2021–2025
- 2,314
- Reviews
- 1,655
- Animal-only studies
- 832
- Registered studies
- 551
Publications per year, 2006–2025
4,530 records in 2016–2025 against 1,208 in 2006–2015; the busiest year was 2025, with 689.
See the numbers
| Year | PubMed records |
|---|---|
| 2006 | 8 |
| 2007 | 16 |
| 2008 | 28 |
| 2009 | 69 |
| 2010 | 96 |
| 2011 | 112 |
| 2012 | 147 |
| 2013 | 160 |
| 2014 | 240 |
| 2015 | 332 |
| 2016 | 376 |
| 2017 | 395 |
| 2018 | 401 |
| 2019 | 432 |
| 2020 | 414 |
| 2021 | 445 |
| 2022 | 400 |
| 2023 | 429 |
| 2024 | 549 |
| 2025 | 689 |
Study types
| All PubMed records | 5,716 |
|---|---|
| Reviews | 1,65529% |
| Animal studies (no human subjects indexed) | 83215% |
| Indexed as clinical trials | 61611% |
| Registered on ClinicalTrials.gov | 551 |
Categories overlap and follow PubMed’s own indexing; recent records may not be indexed yet.
Primary research directions
What 1 of the most-cited and most recent Liraglutide papers report, in their own authors’ terms. Each line links the paper it came from.
Cardiovascular outcomes
In 9,340 people with type 2 diabetes followed for a median 3.8 years, the primary composite cardiovascular outcome occurred in 13.0% of the liraglutide group against 14.9% with placebo (hazard ratio 0.87).
HumansMarso SP 2016The New England journal of medicinePMID 27295427
Most-studied topics
The Medical Subject Headings (MeSH) PubMed indexers most often marked as a main topic, across 400 of the 5,716 records. They describe what the literature is about, not what Liraglutide does.
- Liraglutide235 papers
- Hypoglycemic Agents119 papers
- Diabetes Mellitus, Type 2108 papers
- Glucagon-Like Peptide 163 papers
- Obesity31 papers
- Diabetes Mellitus, Experimental27 papers
- Glucagon-Like Peptide-1 Receptor Agonists16 papers
- Weight Loss14 papers
Key papers
Earliest indexed record
Bayés M (2003). Methods and findings in experimental and clinical pharmacology.
PMID 12949633Most-cited paper · 5,831 citations
Marso SP (2016). The New England journal of medicine.
PMID 27295427Most-cited #2 · 913 citations
Nauck M (2009). Diabetes care.
PMID 18931095Most-cited #3 · 892 citations
Davies MJ (2015). JAMA.
PMID 26284720
Citation counts from NIH iCite, among the 400 records sampled. Titles are left out; open each record on PubMed to read it.
Identity
| CAS | 204656-20-2 |
|---|---|
| Molecular formula | C172H265N43O51 |
| Molecular weight | 3751 g/mol |
| Synonyms | Liraglutide, victoza, Liraglutida, NN2211, Liraglutidum |
Identity data from PubChem, retrieved November 1, 2026, on the Liraglutide page.
How these numbers were counted
- PubMed search, run November 1, 2026:
liraglutide[tiab]re-run it. Study types add PubMed’s own filters (review, clinical trial, animals not humans). - Topics: MeSH major-topic headings counted across up to 400 of the matching records; headings for study set-up (species, sex, age) are left out.
- Citations: NIH iCite citation counts for the same records.
- ClinicalTrials.gov search:
liraglutidere-run it. Any phase, any status.
This page reports what has been published and what papers say they found, with each source linked. It gives no dosing or usage information, and nothing here is a reason to use Liraglutide outside a laboratory.
Wholesale supply
Liraglutide, sourced to order for research.
Not held in the listed catalog. Tell us the vial size and the number of vials and we come back with availability, documentation and pricing in writing.
Liraglutide research questions
How much research has been published on Liraglutide?
PubMed indexes 5,716 records matching Liraglutide (searched November 1, 2026), including 1,655 reviews and 616 records indexed as clinical trials. 2,314 were published in the five years 2021–2025.
When was Liraglutide first described in the literature?
The earliest PubMed record matching Liraglutide is from 2003 (Bayés M, Methods and findings in experimental and clinical pharmacology, PMID 12949633).
What topics does the Liraglutide literature cover?
The subject headings PubMed indexers most often marked as a main topic of Liraglutide papers are Liraglutide, Hypoglycemic Agents, Diabetes Mellitus, Type 2, Glucagon-Like Peptide 1. These describe what the literature is about. Findings from individual papers, with their sources, are summarized on this page.
Is Liraglutide sold for human use?
No. Vanta Foundry supplies it for laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or dietary supplement.
Where can I buy Liraglutide wholesale for research?
We source Liraglutide to order rather than stock it. Tell us the vial size and number of vials on WhatsApp or by email and the quote confirms availability, documentation and pricing.
Research materials supplied by Vanta Foundry are for laboratory research use only. They are not for human or veterinary use and are not drugs, foods, cosmetics or dietary supplements. Websites and payment processing are business services for research-supply brands.
All compounds: research peptide publication statistics.